Analysis of pathological defects in methionine metabolism using a simple mathematical model

被引:23
作者
Prudova, A
Martinov, MV
Vitvitsky, VM
Ataullakhanov, FI
Banerjee, R [1 ]
机构
[1] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA
[2] Natl Res Ctr Hematol, Moscow 125167, Russia
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2005年 / 1741卷 / 03期
关键词
methionine homocysteine; S-adenosylmethionine; methylation; cystathionine beta-synthase;
D O I
10.1016/j.bbadis.2005.04.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Derangements in methionine metabolism are a hallmark of cancers and homocystinuria, an inborn error of metabolism. In this study, the metabolic consequences of the pathological changes associated with the key pathway enzymes, methionine adenosyl transferase (MAT), glycine N-methyl transferase (GNMT) and cystathionine beta-synthase (CBS) as well as an activation of polyamine metabolism, were analyzed using a simple mathematical model describing methionine metabolism in liver. The model predicts that the mere loss of allosteric regulation of CBS by adenosylmethionine (AdoMet) leads to an increase in homocysteine concentration. This is consistent with the experimental data on the corresponding genetic defects, which specifically impair allosteric activation but not basal enzyme activity. Application of the characteristics of transformed hepatocytes to our model, i.e., substitution of the MATI/III isozyme by MATII, loss of GNMT activity and activation of polyamine biosynthesis, leads to the prediction of a significantly different dependence of methionine metabolism on methionine concentrations. The theoretical predictions were found to be in good agreement with experimental data obtained with the human hepatoma cell line, HepG2. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 50 条
[1]   Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma [J].
Avila, MA ;
Berasain, C ;
Torres, L ;
Martín-Duce, A ;
Corrales, FJ ;
Yang, HP ;
Prieto, J ;
Lu, SC ;
Caballería, J ;
Rodés, J ;
Mato, JM .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :907-914
[2]   MECHANISM OF ACTION OF CYSTATHIONINE SYNTHASE [J].
BORCSOK, E ;
ABELES, RH .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1982, 213 (02) :695-707
[3]   EXPRESSION OF HUMAN CYSTATHIONINE BETA-SYNTHASE IN ESCHERICHIA-COLI - PURIFICATION AND CHARACTERIZATION [J].
BUKOVSKA, G ;
KERY, V ;
KRAUS, JP .
PROTEIN EXPRESSION AND PURIFICATION, 1994, 5 (05) :442-448
[4]  
Cai JX, 1996, HEPATOLOGY, V24, P1090
[5]  
Chen YMA, 1998, INT J CANCER, V75, P787, DOI 10.1002/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO
[6]  
2-2
[7]   Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease [J].
Clarke, R ;
Smith, AD ;
Jobst, KA ;
Refsum, H ;
Sutton, L ;
Ueland, PM .
ARCHIVES OF NEUROLOGY, 1998, 55 (11) :1449-1455
[8]  
Desiderio MA, 1998, J CELL PHYSIOL, V174, P125, DOI 10.1002/(SICI)1097-4652(199801)174:1<125::AID-JCP14>3.0.CO
[9]  
2-E
[10]   Alleviation of intrasteric inhibition by the pathogenic activation domain mutation, D444N, in human cystathionine β-synthase [J].
Evande, R ;
Blom, H ;
Boers, GHJ ;
Banerjee, R .
BIOCHEMISTRY, 2002, 41 (39) :11832-11837